Vasorum's vascular implant succeeds in trial; launch expected next year
This article was originally published in Clinica
Executive Summary
AstraPlug, a device designed to seal vascular punctures following percutaneous coronary intervention procedures has shown "excellent results" in its first human trial.
You may also be interested in...
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.
Roche Steals A March In B-cell Lymphoma
New data on Columvi could allow the bispecific’s use as an earlier treatment, giving it a three-year head start on AbbVie and Genmab’s Epkinly.
PureTech Hopes For A Second Lightning Strike
Emerging Company Profile: Seaport Therapeutics believes its technology can alter old drugs to remove their flaws. Just how closely can it follow the example set by Karuna?